SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
XBI Stock Price Chart Interactive Chart >
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $67.40 | 52-week high | $141.50 |
| Prev. close | $70.14 | 52-week low | $61.78 |
| Day low | $66.94 | Volume | 12,647,458 |
| Day high | $69.47 | Avg. volume | 14,700,249 |
| 50-day MA | $81.31 | Dividend yield | 0.00001% |
| 200-day MA | $105.60 |
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 5.73B |
| Net Asset Value (NAV) | $70.13 |
| Options? | Yes |
| Total Holdings | 161 |
XBI Top Holdings
| Symbol | Company | % of Total |
| TPTX | Turning Point Therapeutics Inc | 1.44% |
| HALO | Halozyme Therapeutics Inc | 1.4% |
| ALKS | ALKERMES PLC | 1.35% |
| IONS | Ionis Pharmaceuticals | 1.35% |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 1.31% |
| IOVA | Iovance Biotherapeutics Inc | 1.28% |
| VIR | Vir Biotechnology Inc | 1.22% |
| DVAX | DYNAVAX TECHNO | 1.22% |
| GILD | GILEAD SCI | 1.21% |
| VRTX | Vertex Pharmaceuticals Inc | 1.2% |
XBI Price Returns
| 1-mo | -15.58% |
| 3-mo | -20.80% |
| 6-mo | N/A |
| 1-year | -46.44% |
| 3-year | -18.51% |
| 5-year | -2.70% |
| YTD | -39.80% |
| 2021 | -20.45% |
| 2020 | 48.33% |
| 2019 | 32.56% |
| 2018 | -15.28% |
| 2017 | 43.77% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||